A critical breakthrough in cancer investigation is arising with the use of VHH fragments to re-engage mutated p53. This crucial tumor inhibitor protein is frequently lost in various kinds of cancer, leading https://socialbaskets.com/story7665765/mini-antibodies-revive-p53-new-new-approach-for-cancer-treatment